Pathology of prostate cancer and focal therapy ('male lumpectomy')

Roberta Mazzucchelli, Marina Scarpelli, Liang Cheng, Antonio Lopez-Beltran, Andrea B. Galosi, Ziya Kirkali, Rodolfo Montironi

Research output: Contribution to journalReview article

26 Scopus citations


Focal therapy of the prostate is defined as prostate gland ablation aiming at eradication of unifocal low-risk prostate cancer, and preserving uninvolved (peri-) prostatic tissue and therefore quality of life. The major arguments against focal therapy can be classified under the headings of understaging and multifocality. The argument of understaging highlights the importance of the occasional, but troublesome, finding of a large, extraprostatic or high-grade tumor (Gleason score ≥7) in about a quarter of radical prostatectomy specimens removed from men initially classified as having a low-risk tumor. Indeed, 85% of all prostate cancer cases are multifocal. These concerns can be offset by additional testing: another biopsy, especially a transperineal mapping biopsy, and magnetic resonance imaging (MRI) of the prostate. The technology needed to ablate small regions or sectors of the prostate harboring a known cancer is rapidly becoming available. Cryotherapy is already being used and the preliminary data are encouraging, Ultrasound-guided high-intensity focused ultrasound (HIFU), photodynamic therapy using newly developed light-sensitizing agents, and MRI-guided HIFU are all promising new tools.

Original languageEnglish (US)
Pages (from-to)5155-5161
Number of pages7
JournalAnticancer Research
Issue number12
StatePublished - Dec 1 2009


  • Focal therapy
  • Male lumpectomy
  • Prostate cancer
  • Review

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Fingerprint Dive into the research topics of 'Pathology of prostate cancer and focal therapy ('male lumpectomy')'. Together they form a unique fingerprint.

  • Cite this

    Mazzucchelli, R., Scarpelli, M., Cheng, L., Lopez-Beltran, A., Galosi, A. B., Kirkali, Z., & Montironi, R. (2009). Pathology of prostate cancer and focal therapy ('male lumpectomy'). Anticancer Research, 29(12), 5155-5161.